iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel product candidates with the potential to restore the immune response against cancer. The Company’s innovative pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for improved clinical outcomes, including the TIGIT/CD226 axis and the adenosine pathway. iTeos Therapeutics is headquartered in Watertown, MA with a research center in Gosselies, Belgium.
Company Details
- Employees
- 185
- Founded
- -
- Address
- 139 Main Street, Cambridge,massachusetts 02142,united States
- Phone
- 3271919934
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- iteostherapeutics.com
- HQ
- Cambridge, Massachusetts
Iteos Therapeutics Questions
Iteos Therapeutics's helpline number is 3271919934
Iteos Therapeutics's website is iteostherapeutics.com
Iteos Therapeutics's LinkedIn profile is https://www.linkedin.com/company/iteos-therapeutics-sa
Iteos Therapeutics has
185 employees.
View email and phone details for 185
employees at Iteos Therapeutics.
Iteos Therapeutics's industry is
Biotechnology Research
Iteos Therapeutics's top competitors are
Novadip Biosciences S.a.,
Univercells,
Galapagos,
Biowin,
Quantoom Biosciences,
Celyad Oncology,
Argenx,
Exothera,
Cellistic,
Ucb.
Iteos Therapeutics's categories are Biotechnology Research
Iteos Therapeutics's founding year is 2011
